The Manufacturers Life Insurance Company acquired a new stake in ASP Isotopes Inc. (NASDAQ:ASPI – Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 18,563 shares of the company’s stock, valued at approximately $52,000.
Other large investors have also made changes to their positions in the company. Fielder Capital Group LLC purchased a new position in shares of ASP Isotopes during the second quarter worth $55,000. KKM Financial LLC grew its position in ASP Isotopes by 66.2% during the 3rd quarter. KKM Financial LLC now owns 22,600 shares of the company’s stock worth $63,000 after purchasing an additional 9,000 shares during the period. Rhumbline Advisers purchased a new position in shares of ASP Isotopes during the 2nd quarter valued at about $116,000. HTLF Bank lifted its holdings in shares of ASP Isotopes by 197.0% in the 2nd quarter. HTLF Bank now owns 105,538 shares of the company’s stock valued at $323,000 after buying an additional 70,000 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its holdings in shares of ASP Isotopes by 16.6% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 120,278 shares of the company’s stock valued at $334,000 after buying an additional 17,159 shares during the period. 16.80% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several analysts recently commented on ASPI shares. Canaccord Genuity Group began coverage on ASP Isotopes in a report on Friday, October 4th. They set a “buy” rating and a $4.50 target price on the stock. Canaccord Genuity Group reaffirmed a “buy” rating and set a $4.50 price objective on shares of ASP Isotopes in a research note on Friday, October 18th.
ASP Isotopes Price Performance
NASDAQ:ASPI opened at $5.45 on Wednesday. The stock has a market capitalization of $389.08 million, a PE ratio of -8.89 and a beta of 3.27. ASP Isotopes Inc. has a 52 week low of $1.65 and a 52 week high of $9.33. The company has a quick ratio of 7.54, a current ratio of 7.55 and a debt-to-equity ratio of 0.80. The stock’s 50-day moving average price is $5.68 and its 200-day moving average price is $3.90.
About ASP Isotopes
ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.
Further Reading
- Five stocks we like better than ASP Isotopes
- Financial Services Stocks Investing
- AppLovin Insiders Sell Shares: Stock Price Indicated Higher
- 3 Warren Buffett Stocks to Buy Now
- Broadcom’s Stellar Outlook Sparks Hopes for a Semi Sector Rally
- What is the Dogs of the Dow Strategy? Overview and Examples
- Salesforce’s Clear Path to $400 and Beyond
Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with MarketBeat.com's FREE daily email newsletter.